The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales

Citation
Gf. Fleming et al., The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales, PHARM WORLD, 23(1), 2001, pp. 13-16
Citations number
13
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACY WORLD & SCIENCE
ISSN journal
09281231 → ACNP
Volume
23
Issue
1
Year of publication
2001
Pages
13 - 16
Database
ISI
SICI code
0928-1231(200102)23:1<13:TROTCP>2.0.ZU;2-N
Abstract
Aim: The aim of the present research was to establish the current extent of pharmacists' contact with illicit drug users in Northern Ireland, their wi llingness to provide services for this group and to compare the findings wi th data from a 1995 national survey of community pharmacies in England and Wales. Method:The questionnaire developed by the National Addiction Centre for res earch in England/Wales was used to collect data. It was mailed on two occas ions (March and April 1999) together with a covering letter and a prepaid r eturn envelope to all community pharmacies in Northern Ireland (n=507). A f inal reminder letter was included in the local wholesalers' medical deliver y for the attention of the pharmacist in May 1999. Main Outcome measure: The extent to which Northern Ireland pharmacists had contact with and provided services to illicit drug users compared to pharma cists in England/Wales. Results: A response rate of 67.5% was achieved. Respondents in Northern Ire land were providing fewer services to drug users than those in England/Wale s. Respondents reported dispensing methadone for the treatment of addiction /misuse to only 9 patients, while only 17 pharmacists had been asked to sel l injecting equipment in the previous week and no pharmacist was participat ing in a needle exchange scheme. However, most respondents indicated their willingness to provide such services. Barriers towards the provision of ser vices were, however, highlighted e.g. the need for training and the establi shment of support systems. Conclusion: Pharmacists in Northern Ireland are in a position to contribute to the policy agenda in Northern Ireland for drug misuse, prevention, trea tment and harm minimisation - roles which the survey indicates they are wil ling to embrace. However, training programmes, support systems and adequate remuneration packages must be established before they will be in a positio n to participate fully.